Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof
US11236083B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 24, 2017 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Mar 28, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (I) which can be used as SGK inhibitors; pharmaceutical compositions comprising the compounds of the invention; as well as uses and methods for treating a disease mediated by SGK by administering the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.